Tiziana Life Sciences PLC Stock London S.E.
Equities
GB00B28XMY25
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- GBX | - |
Sales 2022 | - | Sales 2023 | - | Capitalization | 56.17M 76.54M |
---|---|---|---|---|---|
Net income 2022 | -15M -20.44M | Net income 2023 | -17M -23.16M | EV / Sales 2022 | - |
Net cash position 2022 | 17.76M 24.2M | Net cash position 2023 | 936K 1.28M | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.95
x | P/E ratio 2023 |
-3.29
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 32.75% |
Latest transcript on Tiziana Life Sciences PLC
Managers | Title | Age | Since |
---|---|---|---|
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | - |
Vaseem Palejwala
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 20-06-30 |
Willy Simon
BRD | Director/Board Member | 72 | 15-10-31 |
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |